Active Component

PTSD Symptom Presentation Across the Deployment Cycle

Background: Symptom-level variation in posttraumatic stress disorder (PTSD) has not yet been examined in the early post-deployment phase, but may be meaningful etiologically, prognostically, and clinically.

2015
Steenkamp, M. M.
Boasso, A. M.
Nash, W. P.
Larson, J. L.
Lubin, R. E.
Litz, B. T.

PTSD Symptom Presentation Across the Deployment Cycle

Nearly 900 Marines participated in longitudinal study to examine symptom-level variations in posttraumatic stress disorder (PTSD) across the deployment cycle (pre- and several post-deployment time points).

2015
Steenkamp, M. M.
Boasso, A. M.
Nash, W. P.
Larson, J. L.
Lubin, R. E.
Litz, B. T.

PTSD Symptom Increases in Iraq-Deployed Soldiers: Comparison With Nondeployed Soldiers and Associations With Baseline Symptoms, Deployment Experiences, and Postdeployment Stress

This prospective study examined: (a) the effects of Iraq War deployment versus non-deployment on pre- to postdeployment change in PTSD symptoms and (b) among deployed soldiers, associations of deployment/postdeployment stress exposures and baseline PTSD symptoms with PTSD symptom change.

2010
Vasterling, J. J.
Proctor, S. P.
Friedman, M. J.
Hoge, C. W.
Heeren, T.
King, L. A.
King, D. W.

Prevalence of Respiratory Diseases among Veterans of Operation Enduring Freedom and Operation Iraqi Freedom: Results from the National Health Study for a New Generation of U.S. Veterans

The population prevalence of asthma, bronchitis, and sinusitis were investigated among Veterans deployed to Afghanistan and Iraq compared to nondeployed Veterans (N = 20,563; 64% deployed, 36% nondeployed). Data for this study came from the National Health Survey for a New Generation of U.S.

2014
Barth, S. K.
Dursa, E. K.
Peterson, M. R.
Schneiderman, A.